Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO.

被引：1
|
作者：
Terpos, Evangelos
Dimopoulos, Meletios A.
Boccadoro, Mario
Delimpasi, Sosana
Beksac, Meral
Katodritou, Eirini
Moreau, Philippe
Baldini, Luca
Symeonidis, Argiris
Bila, Jelena
Oriol, Albert
Mateos, Maria-Victoria
Einsele, Hermann
Orfanidis, Ioannis
Gries, Katharine S.
Fastenau, John
Kampfenkel, Tobias
Qiu, Yanping
Amin, Himal
Sonneveld, Pieter
机构：
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Univ Torino, Turin, Italy
[3] Gen Hosp Evangelismos, Athens, Greece
[4] Ankara Univ, Ankara, Turkey
[5] Theagen Canc Hosp, Thessaloniki, Greece
[6] Univ Hosp, Hotel Dieu, Hematol, Nantes, France
[7] Univ Milan, Milan, Italy
[8] Univ Patras, Patras, Greece
[9] Univ Belgrade, Belgrade, Serbia
[10] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
[11] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain
[12] Univ Hosp Salamanca, IBSAL, Canc Res Ctr IBMCC USAL CSIC, Salamanca, Spain
[13] Wurzburg Univ, Med Ctr, Wurzburg, Germany
[14] Hlth Data Specialists SA, Dublin, Ireland
[15] Janssen Res & Dev LLC, Raritan, NJ USA
[16] Janssen Res & Dev LLC, Leiden, NJ, Netherlands
[17] Janssen Res & Dev LLC, Beijing, Peoples R China
[18] Erasmus Univ, Med Ctr, Canc Inst, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.8046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Delimpasi, Sosana
    Beksac, Meral
    Katodritou, Eirini
    Moreau, Philippe
    Pompa, Alessandra
    Symeonidis, Argiris
    Bila, Jelena
    Oriol, Albert
    Mateos, Maria-Victoria
    Einsele, Hermann
    Orfanidis, Ioannis
    Gries, Katharine S.
    Fastenau, John
    Liu, Kevin
    He, Jianming
    Kampfenkel, Tobias
    Qiu, Yanping
    Amin, Himal
    Carson, Robin
    Sonneveld, Pieter
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : 481 - 490
  • [2] Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma
    Oriol, Albert
    Ibarra, Gladys
    Abella, Eugenia
    Motllo, Cristina
    Cibeira, Maria-Teresa
    Garcia, Antoni
    Escoda, Lourdes
    Granell, Miquel
    Ben-Azaiz, Randa
    Cervera, Marta
    Cabezudo, Elena
    Fernandez, Carlos
    Rosinol, Laura
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 125 - 135
  • [3] Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN
    Silbermann, Rebecca
    Laubach, Jacob
    Kaufman, Jonathan L.
    Sborov, Douglas W.
    Reeves, Brandi
    Rodriguez, Cesar
    Chari, Ajai
    Costa, Luciano J.
    Anderson, Larry D.
    Nathwani, Nitya
    Shah, Nina
    Bumma, Naresh
    Holstein, Sarah A.
    Costello, Caitlin
    Jakubowiak, Andrzej
    Orlowski, Robert Z.
    Shain, Kenneth H.
    Cowan, Andrew J.
    Gries, Katharine S.
    Pei, Huiling
    Cortoos, Annelore
    Patel, Sharmila
    Lin, Thomas S.
    Voorhees, Peter M.
    Usmani, Saad Z.
    Richardson, Paul G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1257 - 1268
  • [4] Health-Related Quality of Life With Pomalidomide plus Dexamethasone plus Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients
    Reece, Donna
    Bahlis, Nizar J.
    Samaras, Christy Joy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Agarwal, Amit
    Chung, Weiyuan
    Zafar, Faiza
    Siegel, David S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E277 - E278
  • [5] HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Health-Related Quality of Life (HRQoL) Analysis
    Oriol, Albert
    Richardson, Paul G.
    Mateos, Maria-Victoria
    Larocca, Alessandra
    Creixenti, Joan Blade
    Cavo, Michele
    Rodriguez-Otero, Paula
    Norkin, Maxim
    Nadeem, Omar
    Hiemenz, John W.
    Hassoun, Hani
    Touzeau, Cyrille
    Amor, Adrian Alegre
    Paner, Agne
    Maisel, Christopher
    Mazumder, Amitabha
    Raptis, Anastasios
    Puig, Noemi
    Strang, Peter
    Sandberg, Anna
    Jaques, Christian
    Thuresson, Marcus
    Orre, Marie
    Leleu, Xavier
    BLOOD, 2020, 136
  • [6] A health-related quality-of-life (HRQoL) analysis of pomalidomide plus low-dose dexamethasone plus daratumumab in relapsed refractory multiple myeloma (RRMM) after lenalidomide treatment.
    Reece, Donna Ellen
    Bahlis, Nizar J.
    Samaras, Christy Joy
    Sebag, Michael
    Berdeja, Jesus G.
    Ganguly, Siddartha
    Matous, Jeffrey
    Song, Kevin W.
    Seet, Christopher
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand Marquess
    Fonseca, Gustavo A.
    Agarwal, Amit
    Chung, Weiyuan
    Zafar, Faiza
    Siegel, David Samuel DiCapua
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
    Plesner, Torben
    Dimopoulos, Meletios A.
    Oriol, Albert
    San-Miguel, Jesus
    Bahlis, Nizar J.
    Rabin, Neil
    Suzuki, Kenshi
    Yoon, Sung-Soo
    Ben-Yehuda, Dina
    Cook, Gordon
    Goldschmidt, Hartmut
    Grosicki, Sebastian
    Qin, Xiang
    Fastenau, John
    Garvin, Wendy
    Carson, Robin
    Renaud, Thomas
    Gries, Katharine S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (01) : 132 - 139
  • [8] Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Chari, Ajai
    Romanus, Dorothy
    DasMahapatra, Pronabesh
    Hoole, Michael
    Lowe, Maria
    Curran, Chris
    Campbell, Scott
    Bell, Jill A.
    ONCOLOGIST, 2019, 24 (11): : 1479 - 1487
  • [9] Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma
    Kyriakou, Charalampia
    Murphy, Philip
    Petrucci, Maria Teresa
    Bacon, Pamela
    Lewis, Philip
    Gilet, Helene
    Arnould, Benoit
    Vande Broek, Isabelle
    Leleu, Xavier
    BLOOD, 2015, 126 (23)
  • [10] EXPLORATION AND QUANTIFICATION OF THE DETERMINANTS OF BASELINE HEALTH-RELATED QUALITY OF LIFE (HRQOL) FOR PATIENTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kyriakou, C.
    Petrucci, M.
    Welslau, M.
    Leleu, X.
    Vande Broek, I.
    Bacon, P.
    Lewis, P.
    Gilet, H.
    Arnould, B.
    Murphy, P.
    HAEMATOLOGICA, 2013, 98 : 600 - 600
12345